Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| A536110 | Other Identifier | UW Madison | |
| SMPH/ORTHO&REHAB/ORTHO | Other Identifier | UW Madison | |
| Protocol Version 9/14/2020 | Other Identifier | UW Madison |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This proposal aims to investigate a novel light-based treatment to reduce morbidity in shoulder surgical patients. This has potential to improve outcomes and reduce health care utilization associated with infectious complications of shoulder arthroplasty. Participants will be healthy male volunteers at least 18 years of age. They will be on study for approximately 2 days.
Participants will have two study visits (consent plus treatment and swabs for culture). These visits will be conducted at the main UW Hospital, UW Health at the American Center, or UW Health at 1 S. Park. All visits will be conducted in reserved conference rooms at each location.
Once a subject is determined to be eligible and has consented to the study, they will be randomized into one of three treatment groups. Study team has blank envelopes that contain one of the three treatment groups enclosed. After a subject consents to the study, the study team will randomly draw an envelope to assign a treatment arm.
Arm 1. One group will receive 5% topical benzoyl peroxide gel plus 2% chlorhexidine gluconate with 70% isopropyl alcohol
Arm 2. One group will receive blue light therapy plus 2% chlorhexidine gluconate with 70% isopropyl alcohol
Arm 3. One group will receive both of the above treatments
All participants will have their contralateral shoulder serve as the control (2% chlorhexidine gluconate with 70% isopropyl alcohol only). All treatment will be provided by the study team. Participants will also be asked to complete a research intake form.
If C. acnes does grow for a tissue culture, Investigators plan to bank a colony of the bacterium for potential use in a future study. There will be no added risk to research subjects as no additional cultures will be taken and samples will be completely anonymized. The banked samples will simply be a colony of growth from the culture media for storage for possible future use. Samples will be banked for 5 years from the date of study completion after which time the samples will be destroyed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Blue Light Therapy | Active Comparator | FDA cleared blue light product, Omniluxblue (Globalmed Technologies, Glen Elen, CA), which emits a 415 nm blue light irradiance of 40mW/cm2. Following the application of blue light protective eyewear, the blue light therapy device will be centered over the deltopectoral interval according to device standardized use instructions and a 23-minute treatment will be administered to dry skin. As was done in the topical BPO group, following treatment, a skin swab culture of the treatment shoulder will be taken, then both the treatment shoulder and control shoulder will be sterilely prepped with 2% chlorhexidine gluconate solution with 70% isopropyl alcohol and allowed to dry for 3 minutes. Following chlorhexidine preparation, a single set of cultures will be obtained from each shoulder. Participants and research personnel conducting the blue light treatments will be wearing medical grade blue light protective glasses for safety. |
|
| 5% Topical Benzoyl Peroxide Gel | Active Comparator | A pea-sized amount, ~0.5 grams, will be applied to a 10cm strip over the deltopectoral interval beginning the morning 48 hours prior to schedule research visit to obtain cultures. The benzoyl peroxide will be applied on dry skin after a shower. The gel will be applied once in the morning and once in the evening for two consecutive days as well as the morning of the scheduled research visit. Following treatment, a skin swab culture of the treatment shoulder will be taken, both the treatment shoulder and control shoulder will be sterilely prepped with 2% chlorhexidine gluconate solution with 70% isopropyl alcohol and allowed to dry for 3 minutes. Following chlorhexidine preparation, a single set of cultures will be obtained from each shoulder. |
|
| Light and Gel | Active Comparator | Prior to treatment, a skin swab culture will be taken, 5% topical benzoyl peroxide treatment will be performed on dry skin immediately after a shower as described in the above paragraph. Again, five total treatments will be performed prior to research visit. On the day of the research visit, the blue light therapy protocol described above will be performed exactly the same followed by culture obtainment. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 5% Topical Benzoyl Peroxide Gel | Drug | Gel treatment used to treat acne |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With C. Acnes Bacterium Culture After Treatment | Swab will be taken from skin and cultured for approximately 7 days to determine bacteria growth. This result is for the null condition following treatment with either blue light, blue light plus benzoyl peroxide or just benzoyl peroxide but before additional preparation with chlorhexidine. | up to 2 days |
| Median Colony Forming Units (CFU) After Treatment | Quantitative culture analysis between treatment groups after treatment to the shoulder but before chlorhexidine preparation (null condition). | up to 2 days |
| Percentage of Participants in Each Group With Positive C. Acnes Cultures | Comparison of positive Cutibacterium acnes cultures as a binary (yes/no) outcome between treatment arm and control arm following chlorhexidine (CHX) prep. Reported is the percentage of people in each group that had Cutibacterium acnes growth. | up to 2 days |
| Median Colony Forming Units Per mL Treatment vs Control | Samples taken from treatment arm and control arm after chlorhexidine (CHX) preparation on both sides. | up to 2 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Males have a higher incidence of C. Acnes. Inclusion criteria includes males 18 years of age and older, as this is the gender and age group most likely to have C. Acnes.
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Brian F Grogan, MD | University of Wisconsin, Madison | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Wisconsin - Madison | Madison | Wisconsin | 53792 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34478863 | Result | Cotter EJ, Cotter LM, Franczek EB, Godfrey JJ, Hetzel SJ, Safdar N, Dai T, Arkin L, Grogan BF. Efficacy of combinational therapy using blue light and benzoyl peroxide in reducing Cutibacterium acnes bioburden at the deltopectoral interval: a randomized controlled trial. J Shoulder Elbow Surg. 2021 Dec;30(12):2671-2681. doi: 10.1016/j.jse.2021.08.008. Epub 2021 Aug 31. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Volunteers were recruited through fliers around the study institution's facilities, through Clinicaltrials.gov, and informational emails to clinical staff listservs at the study University of Wisconsin - Madison. Participants were enrolled from 10/5/20 through 1/22/21.
| ID | Title | Description |
|---|---|---|
| FG000 | Blue Light Therapy | The blue light therapy device will be centered over the deltopectoral interval according to device standardized use instructions and a 23-minute treatment will be administered to dry skin. Following treatment, a skin swab culture of the treatment shoulder will be taken, then both the treatment shoulder and control shoulder will be sterilely prepped with 2% chlorhexidine gluconate solution with 70% isopropyl alcohol and allowed to dry for 3 minutes. Following chlorhexidine preparation, a single set of cultures will be obtained from each shoulder. |
| FG001 | 5% Topical Benzoyl Peroxide Gel | A pea-sized amount, ~0.5 grams, will be applied to a 10cm strip over the deltopectoral interval beginning the morning 48 hours prior to schedule research visit to obtain cultures. The benzoyl peroxide will be applied on dry skin after a shower. The gel will be applied once in the morning and once in the evening for two consecutive days as well as the morning of the scheduled research visit. Following treatment, a skin swab culture of the treatment shoulder will be taken, both the treatment shoulder and control shoulder will be sterilely prepped with 2% chlorhexidine gluconate solution with 70% isopropyl alcohol and allowed to dry for 3 minutes. Following chlorhexidine preparation, a single set of cultures will be obtained from each shoulder. |
| FG002 | Light and Gel | Prior to treatment, a skin swab culture will be taken, 5% topical benzoyl peroxide treatment will be performed on dry skin immediately after a shower as described in the above paragraph. Again, five total treatments will be performed prior to research visit. On the day of the research visit, the blue light therapy protocol described above will be performed exactly the same followed by culture obtainment. |
| FG003 | Control Shoulder | All participants will have their contralateral shoulder serve as the control (2% chlorhexidine gluconate with 70% isopropyl alcohol only) |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Blue Light Therapy | Blue Light Therapy: Blue light therapy treatment for acne |
| BG001 | 5% Topical Benzoyl Peroxide Gel | 5% Topical Benzoyl Peroxide Gel: Gel treatment used to treat acne |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With C. Acnes Bacterium Culture After Treatment | Swab will be taken from skin and cultured for approximately 7 days to determine bacteria growth. This result is for the null condition following treatment with either blue light, blue light plus benzoyl peroxide or just benzoyl peroxide but before additional preparation with chlorhexidine. | Posted | Count of Participants | Participants | up to 2 days |
|
Participants were contacted at least 1 week following the final research visit to ask for any delayed side effects of treatments, up to 2 weeks on study
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Blue Light Therapy | Blue Light Therapy: Blue light therapy treatment for acne |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Itching or Burning | Injury, poisoning and procedural complications | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Eric Cotter, MD | UW School of Medicine and Public Health | 920.362.9221 | ecotter@uwhealth.org |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 1, 2021 | Feb 7, 2022 | Prot_SAP_001.pdf |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000152 | Acne Vulgaris |
| ID | Term |
|---|---|
| D017486 | Acneiform Eruptions |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012625 | Sebaceous Gland Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010789 | Phototherapy |
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Blue Light Therapy | Device | Blue light therapy treatment for acne |
|
| BG002 | Light and Gel | 5% Topical Benzoyl Peroxide Gel: Gel treatment used to treat acne Blue Light Therapy: Blue light therapy treatment for acne |
| BG003 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Body Mass Index (BMI) | Mean | Standard Deviation | kg/m^2 |
|
| Occupation | Count of Participants | Participants |
|
| Asthma | Count of Participants | Participants |
|
| Autoimmune Condition | Count of Participants | Participants |
|
| Infection Requiring Intravenous Antibiotics | Count of Participants | Participants |
|
| Consume Alcohol | Count of Participants | Participants |
|
| Number of Alcohol Drinks per Week | One drink is 1 12oz beer, 5 ounces of wine, or 1.5 ounces of distilled spirits per the NIH definition. | Mean | Standard Deviation | drinks per week |
|
| OG002 |
| Light and Gel |
5% Topical Benzoyl Peroxide Gel: Gel treatment used to treat acne Blue Light Therapy: Blue light therapy treatment for acne |
|
|
| Primary | Median Colony Forming Units (CFU) After Treatment | Quantitative culture analysis between treatment groups after treatment to the shoulder but before chlorhexidine preparation (null condition). | Posted | Median | Inter-Quartile Range | CFU/mL | up to 2 days |
|
|
|
| Primary | Percentage of Participants in Each Group With Positive C. Acnes Cultures | Comparison of positive Cutibacterium acnes cultures as a binary (yes/no) outcome between treatment arm and control arm following chlorhexidine (CHX) prep. Reported is the percentage of people in each group that had Cutibacterium acnes growth. | Posted | Number | 95% Confidence Interval | percent | up to 2 days |
|
|
|
| Primary | Median Colony Forming Units Per mL Treatment vs Control | Samples taken from treatment arm and control arm after chlorhexidine (CHX) preparation on both sides. | Posted | Median | Inter-Quartile Range | CFU/mL | up to 2 days |
|
|
|
| 0 |
| 20 |
| 0 |
| 20 |
| 6 |
| 20 |
| EG001 | 5% Topical Benzoyl Peroxide Gel | 5% Topical Benzoyl Peroxide Gel: Gel treatment used to treat acne | 0 | 20 | 0 | 20 | 6 | 20 |
| EG002 | Light and Gel | 5% Topical Benzoyl Peroxide Gel: Gel treatment used to treat acne Blue Light Therapy: Blue light therapy treatment for acne | 0 | 20 | 0 | 20 | 6 | 20 |
| EG003 | Control Shoulder | All participants will have their contralateral shoulder serve as the control (2% chlorhexidine gluconate with 70% isopropyl alcohol only) | 0 | 60 | 0 | 60 | 2 | 60 |
| Skin Dryness, Peeling, or Flaking | Injury, poisoning and procedural complications | Systematic Assessment |
|
| bleaching of clothing | Product Issues | Systematic Assessment |
|
| Erythema | Injury, poisoning and procedural complications | Systematic Assessment | transient erythema at application site |
|
| Hyperpigmentation | Injury, poisoning and procedural complications | Systematic Assessment | transient hyperpigmentation |
|
| Warmth at Treatment Site | Injury, poisoning and procedural complications | Systematic Assessment |
|
Not provided
Not provided
Not provided
|
|